A double-blind placebo-controlled trial of topiramate treatment for essential tremor

Neurology

Volumn 59, Issue 1, 2002, Pages 132-134

  Connor, Gregory S ^a  

^a Headache Neurol Ctr of Okla Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ADULT; AMNESIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL TREMOR; FEMALE; HUMAN; MALE; MAXIMUM TOLERATED DOSE; PARESTHESIA; PRIORITY JOURNAL; SCORING SYSTEM; TREMOR; WEIGHT REDUCTION;

EID: 0037046967     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.1.132     Document Type: Article

References (10)

1. Essential tremor
2. Treatment of essential tremor with methazolamide
3. The effect of acetazolamide on essential tremor: An open-label trial
4. Essential tremor
5. An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action
6. Topiramate as a novel treatment for essential tremor
7. Topiramate and essential tremor
8. Definitions and behavioral classifications
9. Clinical rating scale for tremor
10. Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults